Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Leslie Ann Caromile
PSMA Redirects MAPK to PI3K-AKT Signaling to Promote Prostate Cancer Progression
Molecular and Cellular Oncology
Cancer Research
Molecular Medicine
Related publications
FAM83B-mediated Activation of PI3K/AKT and MAPK Signaling Cooperates to Promote Epithelial Cell Transformation and Resistance to Targeted Therapies.
Oncotarget
Oncology
Targeting the PI3K/AKT/mTOR Pathway in Prostate Cancer Development and Progression: Insight to Therapy
Clinical Cancer Drugs
Cancer Research
Toxicology
Oncology
Pharmaceutics
Pharmacology
SU6668 Modulates Prostate Cancer Progression by Downregulating MTDH/AKT Signaling Pathway
International Journal of Oncology
Cancer Research
Oncology
Dampened PI3K/AKT Signaling Contributes to Cancer Resistance of the Naked Mole Rat
Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer
Cancer Research
Cancer Research
Oncology
IDO1 and Kynurenine Pathway Metabolites Activate PI3K-Akt Signaling in the Neoplastic Colon Epithelium to Promote Cancer Cell Proliferation and Inhibit Apoptosis
Cancer Research
Cancer Research
Oncology
PI3K/AKT/mTOR Pathway Alterations Promote Malignant Progression and Xenograft Formation in Oligodendroglial Tumors
Clinical Cancer Research
Cancer Research
Oncology
Erratum To: PI3K/Akt/mTOR Signaling in Medullary Thyroid Cancer: A Promising Molecular Target for Cancer Therapy
Endocrine
TIMP1 Is a Prognostic Marker for the Progression and Metastasis of Colon Cancer Through FAK-PI3K/AKT and MAPK Pathway
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
